[go: up one dir, main page]

ES529068A0 - Un procedimiento para la preparacion de fenotiazonas halogenadas. - Google Patents

Un procedimiento para la preparacion de fenotiazonas halogenadas.

Info

Publication number
ES529068A0
ES529068A0 ES529068A ES529068A ES529068A0 ES 529068 A0 ES529068 A0 ES 529068A0 ES 529068 A ES529068 A ES 529068A ES 529068 A ES529068 A ES 529068A ES 529068 A0 ES529068 A0 ES 529068A0
Authority
ES
Spain
Prior art keywords
phenothiazes
halogenated
procedure
preparation
halogenated phenothiazes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529068A
Other languages
English (en)
Other versions
ES8607256A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of ES8607256A1 publication Critical patent/ES8607256A1/es
Publication of ES529068A0 publication Critical patent/ES529068A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/06Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/46Phenazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/34[b, e]-condensed with two six-membered rings with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/36[b, e]-condensed, at least one with a further condensed benzene ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ES529068A 1983-01-21 1984-01-20 Un procedimiento para la preparacion de fenotiazonas halogenadas. Expired ES8607256A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45992483A 1983-01-21 1983-01-21
US53648783A 1983-09-28 1983-09-28

Publications (2)

Publication Number Publication Date
ES8607256A1 ES8607256A1 (es) 1986-06-16
ES529068A0 true ES529068A0 (es) 1986-06-16

Family

ID=27039516

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529068A Expired ES8607256A1 (es) 1983-01-21 1984-01-20 Un procedimiento para la preparacion de fenotiazonas halogenadas.

Country Status (10)

Country Link
EP (1) EP0115394B1 (es)
AU (1) AU561698B2 (es)
CA (1) CA1262544A (es)
DE (1) DE3478788D1 (es)
DK (1) DK20884A (es)
ES (1) ES8607256A1 (es)
GR (1) GR81709B (es)
IL (1) IL70656A (es)
NZ (1) NZ206795A (es)
PT (1) PT77957B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484745D1 (de) * 1983-10-05 1991-08-01 Merck Frosst Canada Inc Inhibitoren fuer die leukotrien-biosynthese.
EP0136893B1 (en) * 1983-10-05 1989-08-16 Merck Frosst Canada Inc. Benzo[a]phenothiazines and hydro-derivatives and pharmaceutical compositions containing them
EP0155623A3 (en) * 1984-03-19 1985-12-27 Merck & Co. Inc. Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition
DE3411574A1 (de) * 1984-03-29 1985-10-10 Boehringer Mannheim Gmbh, 6800 Mannheim Glycoside von resorufin-derivaten, verfahren zu deren herstellung sowie deren verwendung zur bestimmung der aktivitaet von glycosidasen
US4728735A (en) * 1984-10-15 1988-03-01 Merck & Co., Inc. 10,11-dihydro-dibenzo-[b,f][1,4]-thiazepin derivatives
DE3516001A1 (de) * 1985-05-03 1986-11-06 Boehringer Mannheim Gmbh, 6800 Mannheim Lipasefarbtest
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
EP0239306B1 (en) 1986-03-27 1993-06-02 Merck Frosst Canada Inc. Tetrahydrocarbazole esters
EP0480716A1 (en) 1990-10-12 1992-04-15 Merck Frosst Canada Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5500760A (en) * 1991-09-06 1996-03-19 Donnelly Corporation Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same
US5910854A (en) 1993-02-26 1999-06-08 Donnelly Corporation Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices
EP0612826B1 (en) * 1993-02-26 2000-10-04 Donnelly Corporation Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processing for making such solid films and devices
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
US7446924B2 (en) 2003-10-02 2008-11-04 Donnelly Corporation Mirror reflective element assembly including electronic component
EP1685117B1 (en) 2003-10-31 2015-01-07 Life Technologies Corporation Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
CN101973946B (zh) * 2010-10-15 2012-12-12 上海交通大学 吩嗪-1-羧酸系列衍生物及其制备方法
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
US9868711B2 (en) * 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
WO2016013009A1 (en) * 2014-07-21 2016-01-28 B. G. Negev Technologies And Applications Ltd. (Ben-Gurion University) Phenothiazine/phenothiazone -graphene oxide composite

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4427588Y1 (es) * 1965-04-05 1969-11-17

Also Published As

Publication number Publication date
IL70656A (en) 1988-05-31
PT77957A (en) 1984-02-01
DK20884A (da) 1984-07-22
AU561698B2 (en) 1987-05-14
ES8607256A1 (es) 1986-06-16
GR81709B (es) 1984-12-12
DE3478788D1 (en) 1989-08-03
DK20884D0 (da) 1984-01-18
EP0115394A3 (en) 1985-01-30
IL70656A0 (en) 1984-04-30
EP0115394A2 (en) 1984-08-08
CA1262544A (en) 1989-10-31
PT77957B (en) 1986-06-18
EP0115394B1 (en) 1989-06-28
AU2326984A (en) 1984-07-26
NZ206795A (en) 1987-08-31

Similar Documents

Publication Publication Date Title
ES539625A0 (es) Un procedimiento para la preparacion de derivados de fenetano.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES512882A0 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES523858A0 (es) Un procedimiento para la preparacion de benzotienil benzofuranil o naftil-derivados.
ES530364A0 (es) Un procedimiento para la preparacion de un nucleosido.
ES533753A0 (es) Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas.
ES511123A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES534892A0 (es) Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos.
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES535953A0 (es) Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos.
ES529068A0 (es) Un procedimiento para la preparacion de fenotiazonas halogenadas.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES511124A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES538907A0 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES536455A0 (es) Un procedimiento para la preparacion de un antibiotico bbm-2478.
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES529846A0 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
ES511663A0 (es) Un procedimiento para la preparacion de un heteropoliacido.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES514311A0 (es) Un procedimiento para la preparacion de benzofurasulfamatos.
ES509312A0 (es) Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES511665A0 (es) Un procedimiento para la preparacion de fenilaminoimidazolidinas.
ES509432A0 (es) Un procedimiento para la preparacion de arilaminas.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES529213A0 (es) Un procedimiento para la preparacion de derivados de isoquinuclidina.